The University of the Sciences in Philadelphia and TTC, a drug development data company, have been conducting a multi-year study on the factors associated with improved speed and cost effectiveness in clinical studies.
The study determined that the individual elements used to select CROs can be summarized within a set of five broad dimensions: Processes for Issue Identification and Resolution; the Specifics of Project Execution; Team Chemistry; CRO Experience; and CRO Capabilities. Read the full article here.
What are your thoughts on this topic? Join the discussion in the Optimizing Oncology Clinical Research group on LinkedIn.